DTIL (STOCKS)
Precision BioSciences, Inc. Common Stock
$7.300000
-0.120000 (-1.62%)
Prev close: $7.420000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Amoroso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $212.35M
- Employees
- 67
- P/E (TTM)
- -2.60
- P/B (TTM)
- 4.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.26 | $-0.81 | -0.4542 | -56.37% |
|
Mar 2026 (Q1)
|
$-0.75 | $-0.67 | -0.0819 | -12.26% |
|
Dec 2025 (Q4)
|
$1.05 | $-0.55 | +1.5957 | +292.41% |
|
Sep 2025 (Q3)
|
$-1.84 | $-1.37 | -0.4732 | -34.62% |
Financial Statements
| Revenues | $45.06M |
| Benefits Costs and Expenses | $97.79M |
| Costs And Expenses | $97.79M |
| Operating Expenses | $81.45M |
| Depreciation and Amortization | $1.25M |
| Research and Development | $53.32M |
| Other Operating Expenses | $27.23M |
| Operating Income/Loss | -$36.40M |
| Income/Loss From Continuing Operations After Tax | -$53.62M |
| Income/Loss From Continuing Operations Before Tax | -$52.73M |
| Income/Loss From Equity Method Investments | -$5.96M |
| Net Income/Loss | -$52.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$52.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.28 |
| Diluted Earnings Per Share | -$1.28 |
| Basic Average Shares | 39,164,936 |
| Diluted Average Shares | 39,164,936 |
| Assets | $125.92M |
| Current Assets | $91.55M |
| Prepaid Expenses | $4.00M |
| Other Current Assets | $87.55M |
| Noncurrent Assets | $34.37M |
| Fixed Assets | $964.00K |
| Intangible Assets | $1.09M |
| Other Non-current Assets | $32.31M |
| Liabilities | $80.63M |
| Current Liabilities | $7.14M |
| Accounts Payable | $828.00K |
| Wages | $2.37M |
| Other Current Liabilities | $3.95M |
| Noncurrent Liabilities | $73.49M |
| Equity | $45.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $45.29M |
| Liabilities And Equity | $125.92M |
| Net Cash Flow From Operating Activities | -$51.90M |
| Net Cash Flow From Operating Activities, Continuing | -$51.90M |
| Net Cash Flow From Investing Activities | -$421.00K |
| Net Cash Flow From Investing Activities, Continuing | -$421.00K |
| Net Cash Flow From Financing Activities | $79.92M |
| Net Cash Flow From Financing Activities, Continuing | $79.92M |
| Net Cash Flow | $27.60M |
| Net Cash Flow, Continuing | $27.60M |
| Comprehensive Income/Loss | -$52.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$52.73M |
| Other Comprehensive Income/Loss | $0.00 |